Neurological Symptoms
Neurological manifestations in ME/CFS extend beyond cognitive dysfunction to include sensory, motor, and perceptual abnormalities.
1 Sensory Sensitivities
Many ME/CFS patients develop heightened sensitivity to sensory stimuli that were previously tolerable.
1.1 Photophobia (Light Sensitivity)
Mild to Moderate.
- Discomfort in bright indoor lighting or sunlight
- Need for sunglasses indoors or in dim environments
- Difficulty tolerating computer screens or fluorescent lights
- Preference for dim environments
- Eye strain and headaches triggered by bright light
Severe.
- Inability to tolerate any artificial lighting
- Need to wear sunglasses or eye masks constantly
- Confinement to darkened rooms
- Severe pain triggered by brief light exposure
- Light-triggered migraines or seizure-like episodes
Mechanism. Photophobia likely reflects both central sensitization (amplification of sensory signals in the brain) and mitochondrial dysfunction in retinal cells, which have exceptionally high energy demands. Visual processing itself is energetically expensive, consuming significant ATP.
1.2 Hyperacusis (Sound Sensitivity)
Mild to Moderate.
- Discomfort in noisy environments (restaurants, crowds)
- Difficulty tolerating sudden or loud sounds
- Need for ear protection in normal-volume environments
- Exacerbation of cognitive symptoms by auditory stimulation
- Preference for quiet, low-stimulation environments
Severe.
- Pain from normal conversation volume
- Inability to tolerate any environmental sounds (traffic, appliances, voices)
- Need for soundproofing or constant ear protection
- Sound-triggered crashes or seizure-like episodes
- Complete withdrawal from environments with any noise
Mechanism. Hyperacusis involves central auditory processing abnormalities, potentially related to reduced descending inhibition from the cortex, allowing normal auditory signals to be perceived as excessively loud or painful. The cochlea’s high metabolic demands may also contribute.
1.3 Touch Sensitivity and Allodynia
Clinical Presentation.
- Light touch perceived as painful (allodynia)
- Clothing textures causing discomfort or pain
- Inability to tolerate certain fabrics (tags, seams, tight clothing)
- Hypersensitivity to temperature of touch
- Discomfort from physical contact (hugs, handshakes)
- Skin feeling “raw” or “burned”
Mechanism. Touch sensitivity reflects small fiber neuropathy and central sensitization. Peripheral nerve dysfunction causes abnormal tactile processing, while central amplification interprets benign touch as noxious stimuli.
1.4 Chemical and Odor Sensitivities (Multiple Chemical Sensitivity)
Common Triggers.
- Perfumes, colognes, and fragranced products
- Cleaning chemicals and detergents
- Cigarette smoke and air pollution
- Gasoline and petroleum fumes
- Paint, solvents, and VOCs (volatile organic compounds)
- Pesticides and herbicides
- New carpets, furniture, or building materials (off-gassing)
Symptom Response.
- Headaches or migraines
- Nausea and dizziness
- Respiratory symptoms (shortness of breath, throat irritation)
- Brain fog and cognitive impairment
- Fatigue exacerbation
- Allergic-type reactions (rashes, congestion)
- PEM-like crashes following exposure
Mechanism. Chemical sensitivities may involve mast cell activation (inappropriate degranulation releasing histamine and inflammatory mediators), liver detoxification impairment, and olfactory-limbic dysregulation. The energetic cost of detoxifying chemicals may exceed available metabolic capacity.
1.5 Taste and Smell Alterations
Clinical Presentation.
- Reduced sense of smell (hyposmia) or complete loss (anosmia)
- Distorted smell perception (parosmia)
- Altered taste perception (dysgeusia)
- Metallic taste in mouth
- Food aversions due to altered taste
- Difficulty detecting spoiled food due to reduced olfaction
Mechanism. Olfactory and gustatory dysfunction may reflect neuroinflammation affecting cranial nerves, central processing abnormalities, or zinc deficiency (common in ME/CFS and essential for taste/smell function).
2 Motor and Coordination Symptoms
2.1 Tremor
Clinical Presentation.
- Fine hand tremor, often action-induced
- Tremor worsening with exertion or fatigue
- Difficulty with fine motor tasks (writing, buttoning, using utensils)
- Postural tremor when holding positions
- Voice tremor in some cases
Mechanism. Tremor reflects energy insufficiency in motor control circuits (basal ganglia, cerebellum) and motor neurons. Fine motor control requires continuous rapid adjustments that consume ATP; when energy is marginal, precision degrades, producing tremor.
2.2 Muscle Weakness and Reduced Strength
Clinical Presentation.
- Generalized muscle weakness disproportionate to disuse
- Difficulty lifting objects, climbing stairs, or standing from seated position
- Grip strength reduction
- Proximal muscle weakness (shoulders, hips)
- Weakness worsening with exertion and persisting after rest
Mechanism. Muscle weakness reflects impaired ATP production, not simply deconditioning. Studies show reduced force generation at the cellular level due to mitochondrial dysfunction, distinct from atrophy-related weakness.
2.3 Gait Disturbances
Clinical Presentation.
- Unsteady gait, feeling “off-balance”
- Shuffling or slow walking pace
- Increased fall risk
- Need for mobility aids (canes, walkers, wheelchairs)
- Difficulty with stairs or uneven surfaces
- Gait worsening with fatigue
Mechanism. Gait disturbances reflect cerebellar dysfunction, proprioceptive impairment, muscle weakness, and orthostatic intolerance. Walking requires integration of multiple systems, all of which may be impaired in ME/CFS.
2.4 Muscle Fasciculations and Twitching
Clinical Presentation.
- Spontaneous muscle twitches visible under skin
- Fasciculations in legs, arms, face, or trunk
- Twitching often worsening at rest or before sleep
- Generally benign but distressing
Mechanism. Fasciculations may reflect peripheral nerve hyperexcitability due to electrolyte imbalances, magnesium deficiency, or metabolic stress in motor neurons.
3 Paresthesias and Sensory Disturbances
Clinical Presentation.
- Tingling, numbness, or “pins and needles” sensations
- Burning sensations in hands, feet, or other areas
- Electric shock-like sensations
- Crawling sensations on skin (formication)
- Sensations often not following anatomical nerve distributions
Mechanism. Paresthesias reflect small fiber neuropathy, documented in many ME/CFS patients via skin biopsy. Small nerve fibers are metabolically demanding and vulnerable to energy deficit and oxidative stress.
4 Dizziness and Vertigo
Clinical Presentation.
- Non-spinning dizziness (lightheadedness)
- True vertigo (sensation of room spinning)
- Disequilibrium (feeling unsteady)
- Presyncope (feeling about to faint)
- Symptoms worsening with position changes, exertion, or sensory stimulation
Mechanism. Dizziness in ME/CFS has multiple contributors: orthostatic intolerance (inadequate cerebral perfusion when upright), vestibular dysfunction, cerebral hypoperfusion, and central processing abnormalities.
5 Dysautonomia Across the Spectrum
Autonomic dysfunction is a shared feature of fibromyalgia, ME/CFS, and Long COVID, with overlapping clinical presentations:
Prevalence of POTS
Postural orthostatic tachycardia syndrome (POTS) criteria are met in:
- 20-40% of Long COVID patients (Eldokla and Ali 2022)
- 25-50% of ME/CFS patients
30% of fibromyalgia patients (when actively sought)
Autonomic Abnormalities in Long COVID
Autonomic function testing reveals objective abnormalities in a significant proportion of Long COVID patients: orthostatic intolerance, pathological tilt test responses, and reduced heart rate variability (HRV) measured by RMSSD (Eldokla and Ali 2022).
HRV Patterns
Reduced HRV (particularly RMSSD) is observed across all three conditions, reflecting sympathetic/parasympathetic imbalance.
The similarity in dysautonomic profiles suggests a common dysregulation of the autonomic nervous system rather than distinct pathologies specific to each diagnosis. The substantial underdiagnosis—due to lack of routine tilt testing—contributes to prolonged diagnostic delays.
Objective autonomic testing (HRV measurement, tilt testing) provides measurable evidence of dysautonomia in ME/CFS, fibromyalgia, and Long COVID. The convergence of autonomic abnormalities across these conditions supports a shared biological mechanism and provides a pathway for objective diagnosis.
6 Tinnitus
Clinical Presentation.
- Ringing, buzzing, hissing, or roaring sounds
- Unilateral or bilateral
- Constant or intermittent
- Volume may fluctuate with fatigue, stress, or exertion
- Can be severely disabling and interfere with sleep
Mechanism. Tinnitus may reflect cochlear damage (high metabolic demands make cochlear hair cells vulnerable), auditory nerve dysfunction, or central auditory processing abnormalities.
7 Seizure-Like Episodes
Clinical Presentation.
- Episodes resembling seizures but with normal EEG (non-epileptic)
- Triggered by sensory overload, exertion, or stress
- May include loss of motor control, altered consciousness, or convulsive movements
- Distinct from true epilepsy
Mechanism. Non-epileptic seizure-like episodes may reflect severe autonomic dysfunction, cerebral hypoperfusion, or metabolic crisis in brain tissue.